Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhichuanling injection for acute exacerbation of chronic obstructive pulmonary disease
ChiCTR2300070246Phase 4Completed
- Sponsor
- Taizhou Jiangyan Traditional Chinese Medicine Hospital
- Start
- Apr 2023
- Countries
- 1
01
Overview
Phase 4, open-label trial of Zhichuanling in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Taizhou Jiangyan Traditional Chinese Medicine Hospital. Primary endpoint: Clinical symptom efficacy (control rate) at day 7. Started Apr 2023; status: completed.
02
Drugs
Zhichuanling
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2300070246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070246.